- Home
- ACIU vs FCCO Comparison
ACIU vs FCCO Comparison
Compare ACIU & FCCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- FCCO
- Stock Information
- Founded
- ACIU 2003
- FCCO 1994
- Country
- ACIU Switzerland
- FCCO United States
- Employees
- ACIU N/A
- FCCO N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- FCCO Major Banks
- Sector
- ACIU Health Care
- FCCO Finance
- Exchange
- ACIU Nasdaq
- FCCO Nasdaq
- Market Cap
- ACIU 213.3M
- FCCO 190.8M
- IPO Year
- ACIU 2016
- FCCO 1998
- Fundamental
- Price
- ACIU $2.04
- FCCO $27.27
- Analyst Decision
- ACIU Strong Buy
- FCCO Strong Buy
- Analyst Count
- ACIU 1
- FCCO 2
- Target Price
- ACIU $12.00
- FCCO $30.00
- AVG Volume (30 Days)
- ACIU 109.7K
- FCCO 22.0K
- Earning Date
- ACIU 08-05-2025
- FCCO 10-15-2025
- Dividend Yield
- ACIU N/A
- FCCO 2.34%
- EPS Growth
- ACIU N/A
- FCCO 57.01
- EPS
- ACIU N/A
- FCCO 2.23
- Revenue
- ACIU $36,362,036.00
- FCCO $71,913,000.00
- Revenue This Year
- ACIU N/A
- FCCO $21.83
- Revenue Next Year
- ACIU $1,022.98
- FCCO $28.41
- P/E Ratio
- ACIU N/A
- FCCO $12.27
- Revenue Growth
- ACIU 86.71
- FCCO 21.39
- 52 Week Low
- ACIU $1.43
- FCCO $19.46
- 52 Week High
- ACIU $3.98
- FCCO $27.96
- Technical
- Relative Strength Index (RSI)
- ACIU 44.83
- FCCO 71.73
- Support Level
- ACIU $2.05
- FCCO $27.08
- Resistance Level
- ACIU $2.19
- FCCO $26.36
- Average True Range (ATR)
- ACIU 0.11
- FCCO 0.41
- MACD
- ACIU -0.01
- FCCO 0.12
- Stochastic Oscillator
- ACIU 4.55
- FCCO 91.19
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About FCCO First Community Corporation
First Community Corp is a bank holding company. Along with its subsidiaries, it provides various banking products and services for professionals and small and medium-sized businesses, including consumer and commercial banking, mortgage, brokerage and investment, online banking, and insurance services. The company offers checking, savings, money market, individual retirement, and certificates of deposit accounts, and its lending lines include consumer loans, real estate loans, home improvement loans, home loans, flex loans, construction loans, agricultural loans, and others. The company's reportable segments are; Commercial and Retail Banking, which derives maximum revenue; Mortgage Banking; Investment Advisory and Non-Deposit; and Corporate.